ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Stock price data as of 03/22/2019
Closing price: 216.71
Support price level: N/A
Resistance price level: $302.08
Relative strength index (14-day RSI) 14.2
Beta 1.27
  • BIIB is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • BIIB is one of this month's worst performers with a return of -33.4%, underperforming 90 percent of stocks in the S&P-100.

  • Down 34.3 percent, BIIB is one of this week's biggest decliners.

  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 91.7%.

  • Volatility is forecast to fall over the next month.

  • With RSI < 30, BIIB is oversold. Odds slightly favor a short-term price reversal.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$216.71 $383.83 0.0%
200 day 50 day 20 day 10 day
$326.09 $323.05 $312.56 $300.97
(Annualized standard deviation)
Historical
(5 year)		 Last month Current estimate Next month forecast
37.6% 41.4% 91.7% 44.8%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 24.9% in the next week.

  • 25.4% in the next month.

  • 79.5% in the next year.